
    
      In this three center, prospective, interventional, randomized controlled study we aim to
      determine safety and efficacy of the FEMTO LDV Z8 laser as compared to conventional technique
      in Chinese patients diagnosed with cataract of any severity grade that are eligible to
      undergo cataract surgery with age 50 years and a maximum age of 80 years in China.
    
  